Cargando…
Percutaneous native kidney biopsy in patients receiving antiplatelet agents- is it necessary to stop them routinely?
Percutaneous renal biopsy plays an important role in the investigational approach of the nephrologist. Though the technique and the safety of the procedure has improved over the last two decades it remains an invasive procedure and can be associated with bleeding complications. To minimize the risk...
Autor principal: | Nayak-Rao, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446914/ https://www.ncbi.nlm.nih.gov/pubmed/26060359 http://dx.doi.org/10.4103/0971-4065.147374 |
Ejemplares similares
-
Risk of percutaneous renal biopsy of native kidneys in the evaluation of acute kidney injury
por: Korbet, Stephen M, et al.
Publicado: (2018) -
Bleeding Complications After Percutaneous Native Kidney Biopsy: Results From the Boston Kidney Biopsy Cohort
por: Palsson, Ragnar, et al.
Publicado: (2020) -
The risks associated with percutaneous native kidney biopsies: a prospective study
por: Andrulli, Simeone, et al.
Publicado: (2022) -
Clinical factors influencing the decision to transfuse after percutaneous native kidney biopsy
por: Whittier, William L., et al.
Publicado: (2016) -
Stop taking routine biopsy specimens for the diagnose of a duodenal adenoma!
por: Yamasaki, Yasushi, et al.
Publicado: (2021)